Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Antitumor agents 259. Design, syntheses, and structure-activity relationship study of desmosdumotin C analogs.

Antitumor agents 259. Design, syntheses, and structure-activity relationship study of desmosdumotin C analogs. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Antitumor agents 259. Design, syntheses, and structure-activity relationship study of desmosdumotin C analogs. Abstract Text:

    kyoko nakagawa-gotoKyoko Nakagawa-Goto,tzu-hsuan chenTzu-Hsuan Chen,chieh-yu pengChieh-Yu Peng,kenneth f bastowKenneth F Bastow,jiu-hong wuJiu-Hong Wu,kuo-hsiung leeKuo-Hsiung Lee,

    Desmosdumotin C (1) and its analogs previously showed potent, selective in vitro anticancer activity. To explore structure-activity relationships of 1 and further increase potency and selectivity, 15 novel analogs (7-15 and 21-26) were synthesized and evaluated for cytotoxity against several human tumor cell lines, as well as inhibition of human endothelial (HUVEC) replication. 4-Bromo-3',3',5'-tripropyl analog 26 showed significant cytotoxity against A549, A431, 1A9, and HCT-8 with ED50 values of 1.0, 1.2, 0.9, and 1.3 mug/mL, respectively. Compound 26 also strongly inhibited the growth of matched tumor cells, KB-VIN and its parent cell KB. Furthermore, analogs 13 and 21 were over 5-fold more potent against KB-VIN than KB. Bromination of ring-B and tripropyl functionalization of ring-A enhanced activity, while alkylation of ring-B promoted KB-VIN/KB selectivity. 2-Furyl analog 16 showed selective activity against HUVEC, suggesting that it may have potential as a new prototype for angiogenesis inhibition.

    Antitumor agents 259. Design, syntheses, and structure-activity relationship study of desmosdumotin C analogs. Publishing Authors By Initials

    k nakagawa-gotoK Nakagawa-Goto,th chenTH Chen,cy pengCY Peng,kf bastowKF Bastow,jh wuJH Wu,kh leeKH Lee,

    For similar biochemical phenomena, metabolism, and nutrition: biochemical phenomena: structure-activity relationship research abstracts see: biochemical phenomena, metabolism, and nutrition: biochemical phenomena: structure-activity relationship research

    PUBMED ID PMID:

    MEDLINE DATE:

    Antitumor agents 259. Design, syntheses, and structure-activity relationship study of desmosdumotin C analogs. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Journal of medicinal chemistry

    VOLUME: 50

    Page Numbers: 3354-8

    Journal Abbreviation: J. Med. Chem.

    ISSN: 0022-2623

    DAY: 15

    MONTH: 06

    YEAR: 2007

    Antitumor agents 259. Design, syntheses, and structure-activity relationship study of desmosdumotin C analogs. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9716531

    Antitumor agents 259. Design, syntheses, and structure-activity relationship study of desmosdumotin C analogs. Keywords Mesh Terms:

    KEYWORDS: Structure-Activity Relationship

    MESH TERMS: pharmacology

    Chemical & Substance for Abstract: Antitumor agents 259. Design, syntheses, and structure-activity relationship study of desmosdumotin C analogs. Information

    Substance Name: desmosdumotin C

    Registry Number: 0

    Grant and Affiliation Information for Antitumor agents 259. Design, syntheses, and structure-activity relationship study of desmosdumotin C analogs.

    AFFILIATION: Natural Products Research Laboratories, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NCI

    GRANT: CA17625

    ACRONYM: CA

    MEDLINETA: J Med Chem

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Antitumor agents 259 Design, syntheses, and structure-activity relationship study of desmosdumotin C analogs Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News